Increased circulating CXCL13 levels in systemic lupus erythematosus and rheumatoid arthritis: a meta-analysis

@article{Bao2019IncreasedCC,
  title={Increased circulating CXCL13 levels in systemic lupus erythematosus and rheumatoid arthritis: a meta-analysis},
  author={Yu-Qing Bao and J. Wang and Ziwei Dai and Yan-Mei Mao and J. Wu and H. Guo and Yuan-Rui Xia and D. Ye},
  journal={Clinical Rheumatology},
  year={2019},
  volume={39},
  pages={281-290}
}
  • Yu-Qing Bao, J. Wang, +5 authors D. Ye
  • Published 2019
  • Medicine
  • Clinical Rheumatology
  • Objectives CXC ligand 13 (CXCL13) is known as B cell chemotactic factor (BLC), promoting the migration of B lymphocytes by communicating with its receptor CXCR5, which can be regarded as part of pathogenesis of systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA). This meta-analysis was to evaluate the circulating CXCL13 levels in SLE and RA. Methods All articles were respectively gathered from PubMed, Web of Science, and China National Knowledge Infrastructure (CNKI) (by the end of… CONTINUE READING
    6 Citations

    References

    SHOWING 1-10 OF 47 REFERENCES
    B-cell-attracting chemokine CXCL13 as a marker of disease activity and renal involvement in systemic lupus erythematosus (SLE).
    • L. Schiffer, P. Kümpers, +5 authors M. Schiffer
    • Medicine
    • Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
    • 2009
    • 52
    • PDF
    CXCL13 as a new biomarker of systemic lupus erythematosus and lupus nephritis – from bench to bedside?
    • 35
    • PDF
    Association of CXCL10 and CXCL13 levels with disease activity and cutaneous manifestation in active adult-onset Still’s disease
    • 24
    • PDF
    Serum C-X-C motif chemokine 13 is elevated in early and established rheumatoid arthritis and correlates with rheumatoid factor levels
    • 21